Overexpression of insulin-like growth factor binding protein-5 decreases osteoblastic function in vitro
- PMID: 15589207
- DOI: 10.1016/j.bone.2004.08.011
Overexpression of insulin-like growth factor binding protein-5 decreases osteoblastic function in vitro
Abstract
Skeletal cells synthesize insulin-like growth factors (IGF) and their binding proteins (IGFBP). The effects of IGFBP-5 on bone cell growth and osteoblastic function are controversial, and transgenic mice overexpressing IGFBP-5 exhibit osteopenia. The mechanisms were not explored, and in this study, we investigated the effects of IGFBP-5 overexpression in MC3T3 cells in vitro. MC3T3 cells were transduced with a retroviral vector (pLPCX) or a vector directing IGFBP-5 transcription under the control of a constitutive promoter. Untreated MC3T3 cells expressed alkaline phosphatase, and osteocalcin mRNA 1 week after confluence and at 4 weeks of culture they formed mineralized nodules. IGFBP-5 overexpression delayed the appearance of alkaline phosphatase and osteocalcin mRNA, decreased type I collagen and osteopontin mRNA and alkaline phosphatase activity (APA), and inhibited the formation of mineralized nodules. IGFBP-5 caused a modest stimulation of DNA synthesis. In conclusion, overexpression of IGFBP-5 decreases osteoblastic function possibly by binding IGFs in the bone microenvironment.
Similar articles
-
Transgenic mice expressing selected insulin-like growth factor-binding protein-5 fragments do not exhibit enhanced bone formation.Growth Horm IGF Res. 2004 Aug;14(4):319-27. doi: 10.1016/j.ghir.2004.04.002. Growth Horm IGF Res. 2004. PMID: 15231301
-
Osteoblast-specific expression of insulin-like growth factor-1 in bone of transgenic mice induces insulin-like growth factor binding protein-5.Bone. 2005 Feb;36(2):224-31. doi: 10.1016/j.bone.2004.10.005. Bone. 2005. PMID: 15780948
-
Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia.Endocrinology. 2002 Oct;143(10):3955-62. doi: 10.1210/en.2002-220129. Endocrinology. 2002. PMID: 12239107
-
Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation.Endocrinology. 1997 Oct;138(10):4181-90. doi: 10.1210/endo.138.10.5465. Endocrinology. 1997. PMID: 9322928
-
Insulin-like growth factor binding protein-5 in osteogenesis: facilitator or inhibitor?Growth Horm IGF Res. 2007 Jun;17(3):179-85. doi: 10.1016/j.ghir.2007.01.005. Epub 2007 Feb 21. Growth Horm IGF Res. 2007. PMID: 17317255 Free PMC article. Review.
Cited by
-
Osteoblast differentiation of NIH3T3 fibroblasts is associated with changes in the IGF-I/IGFBP expression pattern.Cell Mol Biol Lett. 2006;11(4):461-74. doi: 10.2478/s11658-006-0038-y. Epub 2006 Sep 26. Cell Mol Biol Lett. 2006. PMID: 17001448 Free PMC article.
-
Insulin-like growth factor-II regulates bone sialoprotein gene transcription.Odontology. 2016 Sep;104(3):271-81. doi: 10.1007/s10266-015-0205-6. Epub 2015 Apr 21. Odontology. 2016. PMID: 25895664
-
Insulin-like growth factor binding protein-6 interacts with the thyroid hormone receptor α1 and modulates the thyroid hormone-response in osteoblastic differentiation.Mol Cell Biochem. 2012 Feb;361(1-2):197-208. doi: 10.1007/s11010-011-1104-y. Epub 2011 Oct 14. Mol Cell Biochem. 2012. PMID: 21997736
-
Growth hormone, insulin-like growth factors, and the skeleton.Endocr Rev. 2008 Aug;29(5):535-59. doi: 10.1210/er.2007-0036. Epub 2008 Apr 24. Endocr Rev. 2008. PMID: 18436706 Free PMC article. Review.
-
Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis.Biochem J. 2006 Apr 1;395(1):1-19. doi: 10.1042/BJ20060086. Biochem J. 2006. PMID: 16526944 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials